Open AccessSafety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study
Author(s) -
F. M. Marty,
C. Y. Man,
C. van der Horst,
B. Francois,
D. Garot,
R. Manez,
V. Thamlikitkul,
J. A. Lorente,
F. Alvarez-Lerma,
D. Brealey,
H. H. Zhao,
S. Weller,
P. J. Yates,
A. F. Peppercorn
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/h62x-n276
Subject(s) - zanamivir , pharmacokinetics , medicine , open label , multicenter study , neuraminidase inhibitor , open label study , phases of clinical research , pharmacology , adverse effect , clinical trial , covid-19 , infectious disease (medical specialty) , randomized controlled trial , disease